Matinas BioPharma Holdings (FRA:6LJ0) Ending Cash Position : €7.20 Mil (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Matinas BioPharma Holdings Ending Cash Position?

Matinas BioPharma Holdings's Ending Cash Position for the quarter that ended in Dec. 2024 was €7.20 Mil.

Matinas BioPharma Holdings's quarterly Ending Cash Position increased from Jun. 2024 (€4.15 Mil) to Sep. 2024 (€9.50 Mil) but then declined from Sep. 2024 (€9.50 Mil) to Dec. 2024 (€7.20 Mil).

Matinas BioPharma Holdings's annual Ending Cash Position declined from Dec. 2022 (€6.68 Mil) to Dec. 2023 (€4.62 Mil) but then increased from Dec. 2023 (€4.62 Mil) to Dec. 2024 (€7.20 Mil).

Matinas BioPharma Holdings Ending Cash Position Historical Data

The historical data trend for Matinas BioPharma Holdings's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Matinas BioPharma Holdings Ending Cash Position Chart

Matinas BioPharma Holdings Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

10.50

18.83

6.68

4.62

7.20

Matinas BioPharma Holdings Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															4.62	1.22	4.15	9.50	7.20

Matinas BioPharma Holdings Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Matinas BioPharma Holdings's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	4.81	+	2.385
	=	7.20

Matinas BioPharma Holdings's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	10.07	+	-2.875
	=	7.20

Matinas BioPharma Holdings Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Matinas BioPharma Holdings's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Matinas BioPharma Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Matinas BioPharma Holdings Inc (FRA:6LJ0) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

MTNB:USA

Address

1545 Route 206 South, Suite 302, Bedminster, NJ, USA, 07921

Website

https://www.matinasbiopharma.com

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.

Matinas BioPharma Holdings Headlines

No Headlines